Respiratory Medicine Case Reports · 2016 · 13 citations · 3 references
Veterinary MedicinePharmacologyPharmacotherapyImmunopathologyInflammationPharmaceutical ToxicologyEosinophilic DisordersPneumonia PharmacotherapyPulmonary ToxicityRespiratory DiseaseEosinophilic PneumoniaInflammatory Bowel Disease TherapyPulmonary Toxicity Mechanisms
Sulfasalazine is a compound of 5-aminosalicylic acid (5-ASA) and sulfapyridine joined by an azo bond. It is a widely used drug in the treatment of chronic inflammatory bowel disease. Fatal toxicity of sulfasalazine arises from its effects on the bone marrow and the resulting blood dyscrasias. Pulmonary toxicity from sulfasalazine is a rather rare finding. Here, we present the case of a patient who developed acute eosinophilic pneumonia with sulfasalazine use.
3
Fibrosing alveolitis and treatment with sulphasalazine
D. Davies, Andrew Macfarlane · Gut · 1974 · 69 citations · Full text
Sulfasalazine and pulmonary infiltrates.
John Baillie · PubMed · 1984 · 19 citations